Melissa Cummings's most recent trade in ESAB Corp was a trade of 1,863 Stock Option (right to buy) done . Disclosure was reported to the exchange on May 8, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ESAB Corp | Melissa Cummings | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2025 | 1,863 | 1,863 | - | - | Stock Option (right to buy) | |
| ESAB Corp | Melissa Cummings | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2025 | 637 | 637 | - | - | Restricted Stock Units | |
| Progyny Inc | Melissa B. Cummings | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Apr 2025 | 56,741 | 56,741 | - | - | Stock Option (Right to Buy) | |
| Progyny Inc | Melissa B. Cummings | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Apr 2025 | 41,667 | 41,667 (0%) | 0% | 0 | Common Stock | |
| ESAB Corp | Melissa Cummings | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2024 | 1,976 | 1,976 | - | - | Stock Options (right to buy) | |
| ESAB Corp | Melissa Cummings | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2024 | 703 | 703 | - | - | Deferred Stock Units |